↓ Skip to main content

Dove Medical Press

New drugs and combinations for the treatment of soft-tissue sarcoma: a review

Overview of attention for article published in Cancer Management and Research, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
7 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
54 Mendeley
Title
New drugs and combinations for the treatment of soft-tissue sarcoma: a review
Published in
Cancer Management and Research, November 2012
DOI 10.2147/cmar.s23257
Pubmed ID
Authors

Neeta Somaiah, Margaret von Mehren

Abstract

Sarcomas are a heterogeneous group of solid tumors arising from either soft tissues or bone, accounting for approximately 1% of all cancers in adults. Management of these diseases has changed little over the past 10 years, with the exception of treatment of gastrointestinal stromal tumors. Reasons for this stagnation include multiple histologies commonly grouped together in clinical trials limiting the understanding of benefit of treatment and limited investigation of molecular targeted therapies. More recently, advances in molecular pathogenesis, the advent of novel and targeted therapeutics, and increasing collaborations between sarcoma investigators has helped move the field forward in the right direction. Here, we review the recent data on novel agents tested for the management of adult soft-tissue sarcomas, excluding gastrointestinal stromal tumors.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 53 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 19%
Student > Ph. D. Student 8 15%
Student > Bachelor 8 15%
Other 7 13%
Student > Master 7 13%
Other 9 17%
Unknown 5 9%
Readers by discipline Count As %
Medicine and Dentistry 20 37%
Agricultural and Biological Sciences 12 22%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Business, Management and Accounting 3 6%
Nursing and Health Professions 3 6%
Other 6 11%
Unknown 6 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2023.
All research outputs
#4,312,343
of 26,253,210 outputs
Outputs from Cancer Management and Research
#145
of 2,100 outputs
Outputs of similar age
#31,119
of 204,644 outputs
Outputs of similar age from Cancer Management and Research
#1
of 9 outputs
Altmetric has tracked 26,253,210 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,100 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,644 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them